Want to see HK:0570 full AI Analyst Report?
China Traditional Chinese Medicine Holdings Co (0570) Stock Price & Analysis
0570 Stock Chart & Stats
- Day’s Range
- HKD 1.14 - HKD 1.18
- 52-Week Range
- HKD 1.12 - HKD 2.40
- Previous Close
- HKD 1.15
- Volume
- 9.79M
- Average Volume (3M)
- 9.71M
- Market Cap
- HKD 5.89B
- Enterprise Value
- HKD 5.96B
- Total Cash (Recent Filing)
- HKD 4.56B
- Total Debt (Recent Filing)
- HKD 1.34B
- Price to Earnings (P/E)
- ―
- Beta
- 0.45
- Next Earnings
- Mar 19, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 03, 2025
- Dividend Yield
- 0.30%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
The relatively conservative balance sheet gives the company financial flexibility during a period of weak profitability. Lower debt and substantial equity backing reduce refinancing pressure, preserve capacity to support operations, and provide a stronger base for recovery if earnings improve.
Recent Cash Generation
Strong operating and free cash flow in the latest two years shows that the business has continued converting operations into cash despite weaker reported earnings. This supports ongoing funding of operations and gives management more flexibility than a loss-making business with persistently negative cash flow.
Healthy Gross Profit
Healthy gross profit indicates that the company’s TCM products continue to generate economic value before operating costs and other items. Preserving this underlying product-level profitability could provide a foundation for earnings recovery if operating expenses and below-gross-profit pressures become more controlled.
Bears Say
Profitability Deterioration
The shift from sustained earlier profits to near-break-even results and then a 2025 net loss is a material weakening in earnings quality. Continued losses would reduce internal funding capacity, weaken returns on shareholder capital, and make recovery dependent on reversing operating-cost or other below-gross-profit pressures.
Declining Revenue Trend
Repeated revenue declines point to an unstable demand or pricing environment rather than consistently expanding sales. A weaker top line can reduce operating leverage, limit the company’s ability to absorb fixed costs, and make it harder to restore margins unless growth returns across its TCM product channels.
Cash-flow Volatility
Although recent cash flow was strongly positive, the longer history includes negative free cash flow and a sharp 2025 slowdown in free-cash-flow growth. This volatility makes the strength of cash conversion less dependable and could complicate investment, shareholder returns, or funding decisions if earnings remain weak.
China Traditional Chinese Medicine Holdings Co News
0570 FAQ
What was China Traditional Chinese Medicine Holdings Co’s price range in the past 12 months?
What is China Traditional Chinese Medicine Holdings Co’s market cap?
When is China Traditional Chinese Medicine Holdings Co’s upcoming earnings report date?
How were China Traditional Chinese Medicine Holdings Co’s earnings last quarter?
Is China Traditional Chinese Medicine Holdings Co overvalued?
Does China Traditional Chinese Medicine Holdings Co pay dividends?
What is China Traditional Chinese Medicine Holdings Co’s EPS estimate?
How many shares outstanding does China Traditional Chinese Medicine Holdings Co have?
What happened to China Traditional Chinese Medicine Holdings Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jun Yang
- Employees
- 14,846
- Website
- www.china-tcm.com.cn
- Address
- HK
China Traditional Chinese Medicine Holdings Co (0570) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 6 | 13 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 2 | 0 | 10 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| HK:0874Guangzhou Baiyunshan Pharmaceutical Holdings Company | ||
| HK:0897Wai Yuen Tong Medicine Holdings Limited | ||
| HK:0512Grand Pharmaceutical Group Limited | ||
| HK:6896Golden Throat Holdings Group Co Ltd | ||
| HK:0719Shandong Xinhua Pharmaceutical Company Limited Class H |







